Bill & Melinda Gates Foundation Cure Vac N.V. Transaction History
Bill & Melinda Gates Foundation
- $82.3 Million
- Q1 2024
A detailed history of Bill & Melinda Gates Foundation transactions in Cure Vac N.V. stock. As of the latest transaction made, Bill & Melinda Gates Foundation holds 1,597,637 shares of CVAC stock, worth $5.43 Million. This represents 5.88% of its overall portfolio holdings.
Number of Shares
1,597,637
Previous 1,625,943
1.74%
Holding current value
$5.43 Million
Previous $6.85 Million
29.29%
% of portfolio
5.88%
Previous 7.61%
Shares
4 transactions
Others Institutions Holding CVAC
# of Institutions
95Shares Held
15.3MCall Options Held
31.4KPut Options Held
137K-
Israel Englander Millennium Management LLC | New York, Ny2.76MShares$9.39 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$6.71 Million0.0% of portfolio
-
Camber Capital Management LP Boston, MA1.75MShares$5.95 Million0.13% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il981KShares$3.33 Million0.0% of portfolio
-
Morgan Stanley New York, NY844KShares$2.87 Million0.0% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $637M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...